Stoke Therapeutics Stock Quote STOK - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

11.70

Bid

11.69

Ask

11.71

Volume

395,164

11.50 Day's Range 12.17

3.35 52 Week Range 16.3999

Market Cap

527.361M

Previous Close

11.65

Open

11.55

Last Trade

11.7018

Last Trade Time

12:32:26

Financial Volume

$ 4,670,037

VWAP

11.818

Average Volume (3m)

1,210,387

Shares Outstanding

44,653,782

Dividend Yield

PE Ratio

-5.04

Earnings Per Share (EPS)

-2.34

Revenue

8.78M

Net Profit

-104.7M

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively... Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.stoketherapeutics.com

Headquarters

Dover, Delaware, USA

Founded

1970

Stoke Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker STOK. The last closing price for Stoke Therapeutics was $11.65. Over the last year, Stoke Therapeutics shares have traded in a share price range of $ 3.35 to $ 16.3999.

Stoke Therapeutics currently has 44,653,782 shares outstanding. The market capitalization of Stoke Therapeutics is $527.36 million. Stoke Therapeutics has a price to earnings ratio (PE ratio) of -5.04.

Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer

– Mr. Hoitt brings more than two decades of successful commercial experience with an emphasis on rare diseases – Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to...

Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today...

Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today...

Stoke Therapeutics Announces Proposed Public Offering

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today...

Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

– As of December 31, 2023, Company had $201.4 million in cash, cash equivalents, and marketable securities, anticipated to fund operations to the end of 2025 – Stoke Therapeutics, Inc. (Nasdaq:...

Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome

– Phase 1/2a End of Study Data: 70mg doses demonstrated substantial and sustained reductions in convulsive seizure frequency on top of the best available anti-seizure medicines; Median reductions...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.65	-12.3595505618	13.35	13.82	11.5	1097857	12.06664045	CS
4	5.69	94.6755407654	6.01	16.3999	5.93	3217791	12.04609374	CS
12	6.82	139.754098361	4.88	16.3999	4.09	1210387	11.32214516	CS
26	7.91	208.707124011	3.79	16.3999	3.35	672915	10.22263916	CS
52	3.09	35.8885017422	8.61	16.3999	3.35	500297	9.43116821	CS
156	-19.36	-62.3309723117	31.06	41.6	3.35	335924	13.39565479	CS
260	-15.51	-57.0011025358	27.21	71.58	3.35	270268	17.81660787	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SHOTWSafety Shot Inc	$ 0.48 (60.00%)	6.57k
CSLRComplete Solaria Inc	$ 0.4082 (54.04%)	4.8M
EGOXNext e GO NV	$ 0.0542 (50.56%)	291.79M
TWGTop Wealth Group Holding Ltd	$ 2.7407 (48.15%)	8.09M
AGBAAGBA Group Holding Ltd	$ 1.385 (34.47%)	108.74M
YYAIConnexa Sports Technologies Inc	$ 1.19 (-43.06%)	8.25M
SBFMSunshine Biopharma Inc	$ 2.0399 (-38.56%)	8.02M
IPDNProfessional Diversity Network Inc	$ 1.19 (-29.17%)	115.72k
BGLCBioNexus Gene Lab Corporation	$ 0.66 (-22.22%)	522.72k
GTIGraphjet Technology	$ 7.538 (-21.56%)	41.47k
EGOXNext e GO NV	$ 0.0542 (50.56%)	291.79M
SQQQProShares UltraPro Short QQQ	$ 12.76 (5.72%)	114.68M
AGBAAGBA Group Holding Ltd	$ 1.385 (34.47%)	108.74M
SINTSiNtx Technologies Inc	$ 0.0426 (6.50%)	84.48M
BSFCBlue Star Foods Corporation	$ 0.0804 (24.84%)	69.47M